CLINICAL_TRIALS
trial_result
· 2021-04-20
Clinical Trial Update: A Safety, Tolerability and Pharmacokinetic Study of CPP-115 [Phase 1]
Summary
Phase 1 study evaluating safety, tolerability, and pharmacokinetics of CPP-115 in cocaine dependency has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Catalyst Pharmaceuticals, Inc. | Conditions: Cocaine Dependency | Phase 1 | Status: COMPLETED | Results posted: 2021-04-20